| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesia and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland; and
Rheumatism Foundation Hospital, Heinola, Finland
Address correspondence and reprint requests to Pekka M. Kairaluoma, MD, Department of Anesthesia and Intensive Care Medicine, Helsinki University Hospital, PO Box 580, Helsinki, FIN-00029 HUS, Finland. Address e-mail to pekka.kairaluoma{at}hus.fi
Paravertebral block (PVB) seems to decrease postoperative pain and postoperative nausea and vomiting (PONV) after breast surgery, but the studies have not been placebo controlled. We studied 60 patients scheduled for breast cancer surgery randomly given single-injection PVB at T3 with bupivacaine 5 mg/mL (1.5 mg/kg) or saline before general anesthesia. The patient and attending investigators were blinded; the PVB or the sham block was performed behind a curtain by an anesthesiologist not involved in the study. The patients given PVB with bupivacaine needed 40% less IV opioid medication (primary outcome variable) in the postanesthesia care unit, had a longer latency to the first opioid dose, and had less pain at rest after 24 h than the control patients (P < 0.01). They also had less PONV in the postanesthesia care unit (P < 0.05), were less sedated until 90 min (P < 0.05), and performed better in the digit symbol substitution test at 90 min and the ocular coordination test 60120 min after surgery (P < 0.05). The average peak bupivacaine plasma concentration was 750 ng/mL. One patient had bilateral convulsions immediately after bupivacaine injection. We conclude that PVB before general anesthesia for breast cancer surgery reduced postoperative pain, opioid consumption, and occurrence of PONV and improved recovery from anesthesia.
IMPLICATIONS: Preoperative single-injection paravertebral block proved a suitable adjunct to a multimodal analgesic regimen: it improved postoperative analgesia and prevented postoperative nausea and vomiting after breast resection or mastectomy with and without associated axillary dissection.
This article has been cited by other articles:
![]() |
J. McElwain, N. M. Freir, C. L. Burlacu, D. C. Moriarty, D. I. Sessler, and D. J. Buggy The Feasibility of Patient-Controlled Paravertebral Analgesia for Major Breast Cancer Surgery: A Prospective, Randomized, Double-Blind Comparison of Two Regimens Anesth. Analg., August 1, 2008; 107(2): 665 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sidiropoulou, O. Buonomo, E. Fabbi, M. B. Silvi, G. Kostopanagiotou, A. F. Sabato, and M. Dauri A Prospective Comparison of Continuous Wound Infiltration with Ropivacaine Versus Single-Injection Paravertebral Block After Modified Radical Mastectomy Anesth. Analg., March 1, 2008; 106(3): 997 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Moller, L. Nikolajsen, S. A. Rodt, H. Ronning, and P. S. Carlsson Thoracic Paravertebral Block for Breast Cancer Surgery: A Randomized Double-Blind Study Anesth. Analg., December 1, 2007; 105(6): 1848 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kairaluoma, M. S. Bachmann, P. H. Rosenberg, and P. J. Pere Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth. Analg., September 1, 2006; 103(3): 703 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vogt, D. S. Stieger, C. Theurillat, and M. Curatolo Single-injection thoracic paravertebral block for postoperative pain treatment after thoracoscopic surgery Br. J. Anaesth., December 1, 2005; 95(6): 816 - 821. [Abstract] [Full Text] [PDF] |
||||
|